Aducanumab for Alzheimer’s disease?
The US licensing of Biogen’s aducanumab as “the first ever disease modifying drug for Alzheimer’s disease” was hailed as a major advance by many. However, in response to the decision, three members…
Read Original Article: Aducanumab for Alzheimer’s disease? »
